Funded startups/Bright Uro, Inc.
BU

Bright Uro, Inc.

SEC filing
Biotechnology · Irvine, CA
Form D on EDGAR
Amount raised$15Msold at filing
Total offering$15M
Investors in the raise35count reported to the SEC
FiledSep 5, 2025first sale Jun 20, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Michael FrazzetteDirector
Kevin HershbergerExecutive Officer
Derek HerreraExecutive Officer, Director
Sherman WilliamsDirector
Kurt AzarbarzinDirector

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/ASep 5, 2025$15M$15MEDGAR
DJul 3, 2025$14.7M$14.9MEDGAR
D/AJul 3, 2025$31M$32.1MEDGAR